Alveomucin (AM) or mucin antigen 3EG5 is produced by alveolocytes of type 2.
Elevated serum levels of
AM were found in patients with interstitial lung diseases (ILD), the degree of
elevation correlating to the
severity of clinical symptoms. AM determination may be of use for ILD
diagnostics and monitoring.